MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
News

Potential Changes to MS Treatment Access in Australia

MStranslate
July 2, 2026
Treatments
AHSCT in MS

MS Auckland Webinar: AHSCT as a Treatment for MS

MStranslate
June 18, 2026
Research, Stem Cells, Treatments

MS Auckland Webinar: Remyelination Research in MS

MStranslate
April 15, 2026
Cambridge, Remyelination, Research
two doctors, a man and a woman, examine an MRI image of the brain

FDA Decision On Tolebrutinib

MStranslate
January 12, 2026
Clinical Trials
A pair of hands around a crystal ball that has the year 2026 written inside it.

Multiple Sclerosis Research In 2026

MStranslate
January 5, 2026
Progressive MS, Remyelination, Treatments
mental health

Silence Is Not The Solution To Mental Health Issues in MS

MStranslate
October 25, 2017
Mental Health, Opinion, Symptoms
Silence Is Not The Solution To Mental Health Issues in MS For a long time, mental health has been associated with a certain stigma in society.  Primarily, this has been due to a number of misconceptions that...
animal models

Animal Models of Multiple Sclerosis – Are They Useful?

MStranslate
October 3, 2017
Research, Understanding Science
Animal models of multiple sclerosis are not perfect.  I think that is an important first point to make.  As we still don’t know what causes multiple sclerosis, we can’t replicate the disease exactly in...
sunscreen

Could Sunscreen be a Treatment for MS?

MStranslate
September 13, 2017
Research, Treatments
Recently, you may have heard about a study that has revealed that sunscreen (or more accurately certain compounds in sunscreen) can prevent the development of disease in a mouse model of multiple sclerosis. ...
lifestyle treatments

Do We Need Clinical Trials for MS Lifestyle Treatments?

MStranslate
August 30, 2017
Lifestyle, Opinion, Treatments
1 Comment
We have been discussing lifestyle factors, such as diet and exercise, a lot recently on MStranslate.  This has been presented both in terms of the reported benefits of these approaches from anecdotal evidence...
lifestyle

Alternative Treatment Approaches in MS Reviewed

MStranslate
August 29, 2017
Lifestyle, Research, Treatments
2 Comments
Across the last few weeks, the MStranslate Facebook page has placed a large focus on lifestyle modifications and how they can be used to help manage multiple sclerosis. As well as gauging how members of the MS...
fatigue

Improving Fatigue: A Goal for New MS Treatments?

MStranslate
August 22, 2017
Fatigue, Research, Symptoms, Treatments
1 Comment
“Doing the little things can make a big difference” - Yogi Berra We constantly marvel at the hard-work, dedication and perseverance of multiple sclerosis researchers around the world.  It is through...
vitamin D

Multiple Sclerosis, Vitamin D & Bone Health

MStranslate
July 24, 2017
Lifestyle, Research, Vitamin D
Research Summary: High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomised controlled trial There has been a lot of online coverage during the past two...
medicinal cannabis

Medicinal Cannabis for Multiple Sclerosis

MStranslate
July 14, 2017
Research, Treatments
1 Comment
Firstly, we would like to thank everyone who contributed to last week's poll gauging the community's interest in access to medicinal cannabis for the management of multiple sclerosis.  Considering the...
MIS416

MIS416 Multiple Sclerosis Trial Results

MStranslate
June 28, 2017
MIS416, Research, Treatments
On Tuesday, Innate Immunotherapeutics released a report outlining the first set of results from their Phase 2b trial on the use of their compound, MIS416, in people with secondary progressive multiple...

Warwick: From Medieval Times to MStranslate

MStranslate
June 21, 2017
Community, MStranslate
Warwick, England.  Famously known as the home of Warwick Castle, an amazing castle built by William the Conqueror in 1068.  The town is situated on the River Avon and is one of those places that just exudes...
  1. 13
  2. 14
  3. 15
  4. 16
  5. 17
  6. 18
  7. 19

Recent Posts

  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Jun    

Archives

Categories

Posts

  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.